BUFFALO, NY, and MOUGIN, France, July 18, 2024 – PostProcess Technologies Inc., the first and only provider of automated and intelligent post-printing solutions for industrial 3D printing, announced today that Sam Heleba, MBA has joined their Board of Directors. Mr. Heleba will be serving on the board alongside other seasoned executives, who help guide the company with insights from their decades of pattern recognition developed from building and leading a variety of successful companies.
With over four decades of experience in the medical device and industrial sectors, Mr. Heleba emerges as a transformative force driving innovation and excellence. Currently President & CEO of Nissha Medical Technologies, headquartered in Buffalo, NY, USA, with nine device manufacturing plants worldwide, he also serves as Executive Vice President for the Medical Technologies Business Unit (MTBU) for Nissha Co. Ltd., a Japanese publicly held company based in Kyoto, Japan (TSE:7915). His visionary leadership and steadfast commitment to pioneering innovation continue to redefine industry standards and shape the future of the market.
Mr. Heleba’s career began with a position in research & development and operations at Morton Thiokol, where his innate passion for innovation ignited. Advancing through crucial sales and marketing roles at Grace, Sam developed his expertise, preparing him for impactful global endeavors. His tenure as director of marketing at TYCO Healthcare (Covidien) showcased his ability to navigate complex landscapes and drive strategic growth initiatives. A graduate of the University of Vermont, Sam holds a B.A. in Chemistry, complemented by an MBA from Babson College, solidifying his multifaceted skill set and strategic acumen. Mr. Heleba has orchestrated over 25 strategic acquisitions throughout his career, catalyzing growth and expansion across both industrial and medical manufacturing. |
“We are thrilled to welcome Sam to our board of directors,” commented Jeff Mize, PostProcess CEO, “His expertise and track record of driving strategic growth in both the medical device and industrial sectors will be invaluable assets to PostProcess’s Board as we navigate the complexities of our industry and pursue new avenues of innovation.”
Mr. Heleba expressed his excitement about joining the Board, stating, “I am excited to join the board of Post Process in support of Jeff Mize and his team. Their technology and innovation are what attracted me to not only invest in the company but lend my help in fostering its growth.”
For more information about PostProcess, visit www.postprocess.com.